ICU Medical Inc
NASDAQ:ICUI
ICU Medical Inc
NASDAQ:ICUI
Price:
102.35 USD
1.63%
Updated:
May 7, 2024
ICU Medical Inc
Revenue
|
ICU Medical Inc
Revenue Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Revenue
$2.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
10%
|
CAGR 10-Years
22%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$3.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
31%
|
CAGR 10-Years
17%
|
ICU Medical Inc
Revenue Breakdown
Breakdown by Geography
ICU Medical Inc
ICU Medical Inc
|
Total Revenue:
2.3B
USD
|
|
United States:
1.4B
USD
|
|
EMEA:
373.6m
USD
|
|
Apac [Domain]:
241.7m
USD
|
|
Other Foreign Countries:
203.8m
USD
|
Breakdown by Segments
ICU Medical Inc
ICU Medical Inc
|
Total Revenue:
2.3B
USD
|
|
Infusion Consumables:
969.1m
USD
|
|
Vital Care:
661m
USD
|
|
Infusion Systems:
629m
USD
|
See Also
What is ICU Medical Inc's Revenue?
Revenue
2.3B
USD
2.3B
USD
Based on the financial report for Dec 31, 2023, ICU Medical Inc's Revenue amounts to 2.3B USD.
What is ICU Medical Inc's Revenue growth rate?
Revenue CAGR 10Y
22%
22%
Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for ICU Medical Inc have been 21% over the past three years , 10% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
